UHealth - University of Miami Health System

E-mail a Friend


Alessia Fornoni, M.D., Ph.D.

General Information

Alessia  Fornoni, M.D., Ph.D.

Contact:

  • Fax: 305-243-3506

Specialties

  • Nephrology - Internal Medicine
  • Internal Medicine

Languages

English, Italian

Clinical Areas

Diabetic nephropathy, glomerular diseases, inherited nephropathies, chronic kidney disease

Certifications

  • American Board of Internal Med-Nephrology

Roles

  • Chief, Katz Family Division of Nephrology and Hypertension
  • Director, Peggy and Harold Katz Family Drug Discovery Center
  • Professor of Medicine

Research Interests

Podocytes and mechanisms of proteinuria

nephrotic syndrome

Diabetes and diabetic complications

lipid biology and insulin signlaing

drug developement

target identification

 

Publications

Awards

Scientific Award Committee
Scientific Award Committee
Professional Development Course, American Society of Nephrology
Stanley Glaser Award
Amgen junior faculty award
Stanley J. Glaser Foundation Biomedical Research Award
Professional development seminar award

Education

2000 Ph.D.
Universita' degli Studi di Pavia
1995 M.D.
Universita' degli Studi di Pavia

Biography

Dr. Fornoni is tenured Professor of Medicine and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine. She is the Chief of the Division of Nephrology and Hypertension and serves as and Director and Chair of the Peggy and Harold Katz Drug Discovery Center. She is also the Associate Director of the MD PhD program. In the year 2013, Dr. Fornoni gained experience in drug development as Global Head of Discovery in Cardiovascular and Metabolism at Hoffman-La Roche in Basel. She is currently the Vice-President and Chief Scientific Officer of L&F Health LLC, a small startup company focused on finding a cure for patients affected by chronic kidney diseases. As a physician-scientist who has maintained a resolutely focused research program that has provided novel and seminal contributions to our understanding of the pathogenesis of kidney disease, her research has been supported by grants from National Institutes of Health, industry and private foundations. She has received prestigious awards, she is a member of ASCI, she serves on the editorial board of Diabetes and Kidney International, she was visiting professor at more than 50 academic institutions and international meetings worldwide. She serves as grant reviewer for NIH, DOD, ADA, AHA, UK-diabetes and the Italian Ministry of Health. Her contributions have been published in high impact journals: Journal of Clinical Investigation, NEJM, Nature Medicine, Science Translational Medicine, Journal of Biological Chemistry, Diabetes among others. She successfully trained several graduate students and post-doctoral fellows, further supporting her accomplishments, dedication and perseverance, and more importantly her unstinted commitment as a physician-scientist. Moving forward, her vision is one that brings industry, investors and not for profit organizations around the table with the intent to match science with innovation and patients’ motivation to find a cure for kidney diseases.

CV

E-mail a Friend